InvestSMART

Invion Limited (ASX: IVX) - Announcements

Current share price for IVX : $0.039 0.001 (2.63%)+

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Invion Conference Presentation 27 Oct 2022 8:51AM $0.010 $0.039 risen by 290%
$4 Photosoft Effective Against Superbugs and Other Pathogens 26 Oct 2022 10:54AM $0.011 $0.039 risen by 271.43%
$4 Photosoft shows activity against Dengue in Preliminary Assay 24 Oct 2022 5:36PM $0.010 $0.039 risen by 290%
$4 Invion Conference Presentation 18 Oct 2022 9:19AM $0.012 $0.039 risen by 239.13%
$4 Activities Report and Appendix 4C 17 Oct 2022 4:17PM $0.012 $0.039 risen by 239.13%
$4 Notice of Annual General Meeting/Proxy Form 14 Oct 2022 9:14AM $0.011 $0.039 risen by 254.55%
$4 Change in substantial holding 10 Oct 2022 10:39AM $0.012 $0.039 risen by 225%
$4 Hudson Institute to Present Photosoft at Combio2022 27 Sep 2022 8:53AM $0.013 $0.039 risen by 212%
$4 Change of Director's Interest Notice - Alistair Bennallack 21 Sep 2022 9:04AM $0.014 $0.039 risen by 178.57%
$4 Section 708A Cleansing Statement 21 Sep 2022 9:01AM $0.014 $0.039 risen by 178.57%
$4 Application for quotation of securities - IVX 21 Sep 2022 8:56AM $0.014 $0.039 risen by 178.57%
$4 INV043 Effective Against Anal Cancer SCC In Vitro 15 Sep 2022 9:04AM $0.012 $0.039 risen by 225%
$4 Change of Director's Interest Notice - Alistair Bennallack 13 Sep 2022 3:43PM $0.014 $0.039 risen by 188.89%
$4 Change of Director's Interest Notice- Alan Yamashita 13 Sep 2022 3:41PM $0.014 $0.039 risen by 188.89%
$4 Change of Director's Interest Notice- Robert Merriel 13 Sep 2022 3:39PM $0.014 $0.039 risen by 188.89%
$4 Change of Director's Interest Notice - Thian Chew 13 Sep 2022 3:38PM $0.014 $0.039 risen by 188.89%
$4 Notification regarding unquoted securities - IVX 13 Sep 2022 3:03PM $0.014 $0.039 risen by 188.89%
$4 Response to ASX Aware Query 13 Sep 2022 11:29AM $0.013 $0.039 risen by 200%
$4 Photosoft Shows Activity Against Zika Virus 8 Sep 2022 9:37AM $0.013 $0.039 risen by 200%
$4 Appendix 4G and Corporate Governance Statement 18 Aug 2022 8:56AM $0.010 $0.039 risen by 290%
$4 Appendix 4E and Annual Report 18 Aug 2022 8:50AM $0.010 $0.039 risen by 290%
$4 Activities Report and Appendix 4C 21 Jul 2022 8:52AM $0.010 $0.039 risen by 290%
$4 Investor Presentation 27 Jun 2022 1:22PM $0.008 $0.039 risen by 387.50%
$4 Notification regarding unquoted securities - IVX 20 Jun 2022 9:44AM $0.008 $0.039 risen by 387.50%
$4 Change of Director's Interest Notice - Alistair Bennallack 20 Jun 2022 9:40AM $0.008 $0.039 risen by 387.50%

226 - 250 of 712 results

Page 10 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.